Kawasaki disease Flashcards

1
Q

Provide a brief description of kawasaki disease. Where is it the most common vasculitis. What is the etiology

A

Kawasaki disease (KD, previously called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood, particularly in East Asia. It is typically a self-limited condition, with fever and other acute inflammatory manifestations lasting for an average of 12 days if not treated. The underlying etiology is unknown.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some of the cardiovascular complications of kawasaki disease?

A
  • coronary artery aneurysms
  • cardiomyopathy with depressed myocardial contractility and heart failure
  • myocardial infarction
  • arrhythmias
  • peripheral arterial occlusion
    • These complications may cause significant morbidity and mortality, particularly in children who are inadequately treated. The frequency of aneurysm development and mortality has dramatically decreased as a result of intravenous immune globulin therapy. Early diagnosis is critical to achieve the optimal treatment result.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the epidemiology of Kawasaki disease

A
  • Greatest incidence in East Asia or Asian ancestry living in other parts of the world
  • Boys are affected more commonly than girls
  • 80-90% of cases occur in kids < 5 years old
  • Uncommon in kids < 6 months
  • Occurrence beyond late childhood is rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the etiology of Kawasaki disease

A

Unknown etiology

Infection by one or more agents that usually cause an asymptomatic or nonvasculitic condition in most children but results in KD in genetically predisposed individuals fits the epidemiologic data well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What vessels are affected in kawasaki disease

A

KD is a systemic, inflammatory illness that particularly affects medium-sized arteries, especially the coronary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does blood vessel damage occur in kawasaki disease?

A

Blood vessel damage appears to result from inflammatory cell infiltration into vascular tissues

The stimulus for this infiltration is unknown, but it is most profound in the coronary arteries and can involve destruction of luminal endothelial cells, elastic lamina, and medial smooth muscle cells in severe cases

Inflammatory cells infiltrating the coronary arteries can include neutrophils, T cells (particularly CD8 T cells), eosinophils, plasma cells (particularly immunoglobulin A [IgA] producing), and/or macrophages. Macrophages are not prominent participants in any other type of vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does aneurysm formation occur in kawasaki disease?

A

The destruction of elastin and collagen fibers and loss of structural integrity of the arterial wall lead to dilatation and aneurysm formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are neutrophilic infiltrates involved in kawasaki disease?

A

Yes. A neutrophilic infiltrate is observed in the arterial wall in fatalities that occur within the first two weeks after fever onset and may represent an innate immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are antibodies/immune complexes involved in the pathogenesis of kawasaki disease?

A

Plasma cells producing oligoclonal IgA antibodies are found in the arteries and respiratory tract of children with KD

Immune complexes are sometimes detected in the peripheral blood in KD, but they are not observed to form deposits in affected tissues and do not appear to correlate with the development of coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the supporting points for the theory of an infectious etiology for kawasaki disease

A

Many epidemiologic data suggest that KD is caused or triggered by a transmissible agent or agents. Support for this theory is derived from the following similarities between KD and other pediatric infectious conditions:

●KD is characterized by a febrile exanthem with lymphadenitis and mucositis. These are features similar to those of contagious diseases, such as adenovirus infection, measles, and scarlet fever.

●There is a seasonal increase in disease incidence in the winter and summer in many geographic areas.

●The disease often occurs in epidemics, and a geographic wave-like spread of illness during epidemics has been noted.

●Boys are more susceptible than girls. In general, the “set-point” of the immune system varies between genders, leading to an overall higher incidence and morbidity of a variety of infections in males (eg, meningitis , Campylobacter enteritis) and a higher incidence of autoimmune diseases in females.

●Siblings of children with KD in Japan are at increased risk for developing the disease, which usually occurs within one week of onset of the index case.

●The disease is common among children younger than five years but rare in those younger than six months. The rarity in infants may be explained by transfer of passive immunity to the relatively common infectious trigger(s) by transplacentally acquired maternal antibodies.

●There is spatial and temporal clustering of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the genetic factors/genes which may be involed in having increased susceptibility to Kawasaki disease?

A

●Inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) gene on chromosome 19q13.2 . ITPKC acts as a negative regulator of T cell activation, which includes transcription of interleukin 2 (IL-2). The single nucleotide polymorphism (SNP) associated with KD susceptibility results in a weaker inhibitory effect upon T cell activation. Patients with this SNP may have a more vigorous T cell response during an inflammatory disease, such as KD, compared with those without this allelic change. However, this polymorphism is not common enough even in the Japanese population to explain the vast majority of cases of KD.

●Angiopoietin 1 (ANGPT1) and vascular endothelial growth factor A (VEGFA) genes. Expression of angiopoietin 1 is upregulated and VEGF is downregulated in patients with acute versus convalescent KD, suggesting disruption of vascular homeostasis.

●The genes encoding the chemokine receptor CCR5 and its major ligand CCL3L1.

●The adenosine triphosphate (ATP)-binding cassette, subfamily C, member 4 (ABCC4) gene. ABCC4 is a cyclic nucleotide transporter involved in migration of dendritic cells and cellular efflux of prostaglandin.

GWAS have revealed other potential susceptibility loci, including a functional polymorphism in the immunoglobulin G receptor gene (FCGR2A). In addition to being a putative susceptibility factor, ITPKC is associated with an increased risk of coronary artery aneurysms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical features of kawasaki disease? What are the diagnostic criteria?

A

The clinical features of KD reflect widespread inflammation of primarily medium-sized muscular arteries. Diagnosis is based upon evidence of systemic inflammation (eg, fever) in association with signs of mucocutaneous inflammation. The characteristic bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, rash, extremity changes, and cervical lymphadenopathy typically develop after a brief nonspecific prodrome of respiratory or gastrointestinal symptoms. These characteristic clinical signs are the basis for the diagnostic criteria for KD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

For each of the main presenting features of kawasaki disease, how often do they present in affected cases?

A
  • Oral mucous membrane findings are seen in approximately 90 percent of cases of KD
  • polymorphous rash in 70 to 90 percent
  • extremity changes in 50 to 85 percent
  • ocular changes in >75 percent
  • cervical lymphadenopathy in 25 to 70 percent.

These findings are often not present at the same time, and there is no typical order of appearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe fever as a clinical manifestation of kawasaki disease?

A
  • An elevated body temperature is the most consistent manifestation of KD.
  • minimally responsive to antipyretic agents, and it typically remains above 38.5ºC (101.3ºF) during most of the illness. On the other hand, fever may be intermittent and may be missed by parents who use tympanic, temporal, axillary, or similar temperature measurement methods that are less reliable than oral or rectal methods. Thus, the diagnosis should be considered in all children with prolonged, unexplained fever ≥5 days but should still be considered in seemingly afebrile children who have other findings consistent with KD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe conjunctivitis as a clinical manifestation of kawasaki disease

A
  • Bilateral nonexudative conjunctivitis is present in more than 90 percent of patients
  • Predominant bulbar injection typically begins within days of the onset of fever, and the eyes often have a significant erythema, which characteristically spares the limbus.
  • Frequently photophobic.
  • anterior uveitis may develop in up to 70 percent of children with ocular findings; therefore, slit-lamp examination may be helpful in ambiguous cases. The presence of uveitis provides further evidence for the diagnosis of KD since it is more commonly seen in KD than in other diseases with similar presentations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe mucositis as a clinical manifestation of Kawasaki disease

A
  • Mucositis often becomes evident as KD progresses
  • Cracked, red lips and a “strawberry tongue” are characteristic. The latter is a result of sloughing of filiform papillae and denuding of the inflamed glossal tissue. The bumps on the “strawberry” are the remaining fungiform papillae.
  • manifestations of oral mucositis may occur singly, in a very mild form, or not at all.
  • Discrete oral lesions, such as vesicles or ulcers, and tonsillar exudate are suggestive of a disease process other than KD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe rash as a clinical manifestation of kawasaki disease?

A
  • The cutaneous manifestations of KD are polymorphous.
  • Rash usually begins during the first few days of illness, typically as perineal erythema and desquamation, followed by macular, morbilliform, or targetoid skin lesions of the trunk and extremities.
  • Vesicular or bullous lesions generally are not observed, but KD may trigger a psoriasiform eruption in children not previously recognized to have psoriasis.
  • Patients may also have redness or crust formation at the site of Bacille Calmette-Guérin (BCG) inoculation. This finding is more useful for increasing the level of suspicion for KD in countries where BCG vaccine is routinely given
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the extremity changes as a clinical manifestation of kawasaki disease?

A
  • Changes of the extremities are generally the last manifestation to appear.
  • Children develop an indurated edema of the dorsum of their hands and feet and a diffuse erythema of their palms and soles.
  • The convalescent phase of KD is often characterized by sheet-like desquamation that begins in the periungual region of the hands and feet and by linear nail creases (Beau’s lines). The prevalence of periungual desquamation in patients with KD has been reported to vary from 68 to 98 percent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe lymphadenopathy as a clinical manifestation of kawasaki disease

A
  • Cervical lymphadenopathy is the least consistent feature of KD, absent in as many as one-half to three-quarters of children with the disease.
  • lymphadenopathy tends to primarily involve the anterior cervical nodes overlying the sternocleidomastoid muscles.
  • Often, only a single, large node is palpable, although ultrasound imaging of the neck typically reveals numerous discrete nodes arranged like a bunch of grapes.

Diffuse lymphadenopathy or other signs of reticuloendothelial involvement (eg, splenomegaly) should prompt a search for alternative diagnoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe cardiac findings as a clinical manifestation of kawasaki disease

A
  • Cardiovascular findings are not part of the diagnostic criteria of KD, but they support the diagnosis since most conditions that mimic KD do not involve the heart.
  • Cardiac manifestations during the first week to 10 days of illness may include tachycardia out of proportion to the degree of fever and gallop sounds.
  • These physical exam findings are the result of lymphocytic myocarditis that is ubiquitous in children with KD. In addition, heart sounds may be muffled due to a pericardial effusion, which is detected in approximately 30 percent of children with KD. Such effusions are usually small; significant fluid collections and tamponade are rare.

With improved echocardiographic techniques and better understanding of age and sex norms for CA diameters, approximately 30 percent of patients with KD are found to have CA dilatation at diagnosis. Frank aneurysms are usually not seen until after day 10 of illness. Severely ill patients, particularly young infants, may develop fusiform aneurysms of other nonvisceral medium-sized arteries, most characteristically involving the brachial arteries. These are easily palpable or visible in the axillae, although they may be mistaken for enlarged lymph nodes. In addition, young infants may have cold, pale, or cyanotic digits of the hands and feet due to reduced perfusion. Gangrene may, in rare cases, cause loss of fingers or toes during this acute period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Is arthritis a common feature of kawasaki disease? How often does it occur?

A

Arthritis is not included in the diagnostic criteria but has been reported in 7.5 to 25 percent of patients with KD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are other nonspecific findings in kawasaki disease patients that commonly occur during the prodrome of the illness, 7-10 days before the typical mucocutaneous features develop?

A

●Diarrhea, vomiting, or abdominal pain – 61 percent

●Irritability – 50 percent (older children with KD more commonly present with lethargy than irritability)

●Vomiting alone – 44 percent

●Cough or rhinorrhea – 35 percent

●Decreased oral intake – 37 percent

●Joint pain – 15 percent

Patients with gastrointestinal involvement often have pseudo-obstruction on radiologic studies. The presentation of gastrointestinal symptoms before typical KD features may delay the diagnosis and lead to unnecessary invasive procedures including surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Infants with kawasaki disease are at increased risk of…?

A

CA Aneurysms, possibly in part because of delay in treatment due to their lack of diagnostic criteria

Even in infants diagnosed and treated before the 10th day of illness, the incidence of CA abnormalities is significantly higher than it is in older patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are some laboratory findings which might support the diagnosis of kawasaki disease?

A

No laboratory studies are included among the diagnostic criteria for typical KD. However, certain findings may support the diagnosis of KD, particularly in incomplete cases:

●Systemic inflammation is characteristic of KD. Elevated ESR/CRP, thrombocytosis that generally develops after the seventh day of illness, leukocytosis, and a left-shift (increased immature neutrophils) in the white blood cell (WBC) count.

Treatment with intravenous immune globulin (IVIG) usually raises the ESR, so this lab test should not be measured after a child receives IVIG. On the other hand, control of inflammation by IVIG accelerates the decrease in CRP, making this a more useful marker of disease activity in a treated child.

Ferritin is another acute-phase reactant that is elevated in inflammatory conditions such as KD, usually less than five times the upper limit of normal.

Platelet counts generally rise by the second week of illness. In some studies, the degree of thrombocytosis correlates with the risk of coronary artery (CA) changes in KD.

Thrombocytopenia, high triglycerides, low sodium, elevated liver function tests, and monocytes/macrophages in cerebral spinal fluid (CSF) can all be signs of subclinical MAS and may warrant further diagnostic testing.

●Children with KD often present with a normocytic, normochromic anemia. Hemoglobin concentrations more than two standard deviations below the mean for age are noted in one-half of patients within the first two weeks of illness.

●Urinary microscopy commonly reveals WBCs. Pyuria is usually of urethral origin and therefore may be missed on urinalyses obtained by bladder tap or catheterization. The WBCs are not polymorphonuclear leukocytes and therefore are not detected by dipstick tests for leukocyte esterase. Thus, children with suspected KD should have a clean voided or bagged urine specimen collected for microscopic examination in order to detect this characteristic feature.

●Transaminitis can occur. In addition, a minority of children develop obstructive jaundice from hydrops of the gallbladder.

●CSF may display a mononuclear pleocytosis without hypoglycorrhachia (decreased CSF glucose) or elevation of CSF protein.

●Similarly, arthrocentesis of inflamed joints in KD typically demonstrates a pleocytosis, with 125,000 to 300,000 WBCs/mm3, primarily neutrophils.

●Children with KD develop significant perturbations in serum lipid profiles, including elevated triglycerides and low-density lipoproteins, and depressed high-density lipoproteins, as is often observed in a variety of infectious and inflammatory conditions. A return to normal generally occurs within weeks or months following IVIG therapy, though abnormalities may persist for years in children who are not treated with IVIG.

●Hyponatremia (serum sodium <135 mEq/L) may be seen and is associated with an increased risk of CA aneurysms.

25
Q

What are the diagnostic criteria for kawasaki disease?

A

Diagnosis of KD according to the criteria established by Tomisaku Kawasaki in 1967 requires the presence of fever lasting ≥5 days, combined with at least four of the five following physical findings, without an alternative explanation:

●Bilateral bulbar conjunctival injection

●Oral mucous membrane changes, including injected or fissured lips , injected pharynx, or strawberry tongue

●Peripheral extremity changes, including erythema of palms or soles, edema of hands or feet (acute phase), or periungual desquamation (convalescent phase)

●Polymorphous rash

●Cervical lymphadenopathy (at least one lymph node >1.5 cm in diameter)

Redness or crust formation at the site of Bacille Calmette-Guérin (BCG) inoculation is also suggested as a useful sign in several diagnostic guidelines.

Rash and conjunctival injection are seen with many illnesses, but other KD features, such as red, cracked lips and redness and swelling of the hands and feet, are unusual in the illnesses in the differential diagnosis and should increase the suspicion for KD

26
Q

Incomplete Kawasaki disease should be suspected in…?

A

Incomplete KD should be suspected in patients less than six months of age with unexplained fever ≥7 days, even if they have no clinical findings of KD, and in patients of any age with unexplained fever ≥5 days and only two or three clinical criteria.

An algorithmic approach can help identify such cases and thereby significantly decrease the number of children who develop CA abnormalities despite not meeting criteria for the disease

27
Q

What blood tests are typically obtained on which in whome a diagnosis of KD is being considered?

A

●Complete blood counts with differential white blood cell (WBC) counts

●Liver function tests including aspartate transaminase (AST), alanine transaminase (ALT), and albumin

●C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)

●Urinalysis

Elevated WBC and platelet counts, transaminases, and acute-phase reactants, as well as anemia and pyuria, are suggestive of KD.

In addition, when specific mimics of KD are strongly suspected, studies that are more specific for these alternative diagnoses may help confirm the diagnosis. These can include rapid viral testing (eg, adenovirus), serologic testing for leptospirosis and other bacterial infections, and blood cultures.

28
Q

Describe the use of echocardiography in KD management

A

Echocardiography should be performed in all patients with KD as soon as the diagnosis is suspected in order to establish a reference point for longitudinal follow-up and treatment efficacy. In addition, initial CA diameter is a factor in identifying patients at high risk of developing a coronary aneurysm and therefore warranting augmentation of initial intravenous immune globulin (IVIG) therapy. Finally, CA diameters are useful for identifying patients who should be treated with IVIG despite failing to meet classical diagnostic criteria for KD.

29
Q

The Differential diagnosis of Kawasaki disease includes?

A
  • Measles, echovirus, adenovirus, and EBV – These viral illnesses may share many of the signs of mucocutaneous inflammation, but they typically have less evidence of systemic inflammation and generally lack the extremity changes seen in KD.
  • Toxin-mediated illnesses, especially group A streptococcal infections (eg, scarlet fever and toxic shock syndrome)
  • Rocky Mountain spotted fever and leptospirosis – Headache and gastrointestinal complaints typically are prominent features of these infections
  • Drug reactions such as Stevens-Johnson syndrome or serum sickness
  • Systemic juvenile idiopathic arthritis (JIA) – Children with this condition generally lack the conjunctival and oral findings of KD.
30
Q

How much does prompt IVIG therapy improve incidence of CA in kawasaki disease?

A

Treatment with intravenous immune globulin (IVIG) within the first 10 days of illness reduces the prevalence of coronary artery (CA) aneurysms fivefold compared with children not treated with IVIG

31
Q

Describe the evaluation of suspected incomplete Kawasaki disease?

A
32
Q

Describe the acute treatment of Kawasaki disease

A

IVIG 2g/kg over 10-12hr AND Aspirin 30-50mg/kg/day or 80-100mg/kg/day divided every 6hr orally until patient is afebrile for at least 48 hours

33
Q

Describe the treatment of Kawasaki disease in the convalescent stage

A

Aspirin 3-5mg/kg once daily orally until 6-8wk after illness onset if normal coronary findings throughout course

34
Q

What is the long term therapy for patients with coronary abn in kawasaki disease?

A

Aspirin 3-5mg/kg once daily orally

Clopipdogrel 1mg/kg/day (max 75mg/day)

Most experts add warfarin or LMWH for patients at high risk of thrombosis

35
Q

What is the treament for acute coronary thrombosis in Kawasaki disease?

A

Prompt fibrinolytic therapy with tissue plasminogen activator or other thormbolytic agent under supervision of a paediatric cardiologist

36
Q

What are treatment options for IVIG-Resistant patients with Kawasaki disease?

A
37
Q

Describe an algorithm for treatment of Kawasaki disease (UTD). What criteria is used to determine if children are likely to be IVIG-resistent?

A
38
Q

What defines IVIG-resistant Kawasaki disease and how often does it occur?

A

15% of patients have IVIG-resistant KD. Defined by persistent or recrudescent fever 36hr after completion of initial IVIG infusion

39
Q

What are some complications of Kawasaki disease?

A

KD + aneurysms –> MI, angina, sudden death

Aspirin is continued indefinitely in pts with coronary aneurysms

Acute thrombosis can occur

Pts with coronary artery stenosis and inducible ischaemia may be managed with CABG or catheter interventions, including percutaneous transluminal coronary rotational ablation, directional coronary atherectomy, and stent implantation

Pts undergoing long-term aspirin Tx should get annual influenza vaccine to redue risk of Reye syndrome

40
Q

When should Echo be performed in kawasaki disease patients?

A

At diagnosis and again after 1-2 weeks of illness. If results are normal a repeat study should be done at 6-8 weeks after onset of illness. If abnormal initially or at 1-2 weeks after illness, or if pt has recurrent fever or symptoms, more frequent TTE may be needed

41
Q

What is the incidence of recurrent kawasaki disease?

A

Acute KD recurs in 1-3% of cases

42
Q

50% of coronary artery aneurysms regress to normal lumen diameter by … after the illness, with smaller aneurysms being more likely to regress

A

1-2yr

43
Q

Giant aneurysms in KD … to regress to normal lumen diameter and are most likely to lead to…

A

less likely, thormbosis or stenosis

44
Q

All children with a history of kawasaki disease should be counseled regarding a …

A

heart-healthy diet, adequate amounts of exercise, tobacco avoidance, and intermittent lipid monitoring

45
Q

What percentage of kids with kawasaki that do not get treated go on to develop coronary artery aneurysms?

A

20-25%

46
Q

What percentake of kids with kawasaki disease who are treated with IVIG go on to develop coronary artery aneurysms?

A

<5%

47
Q

Kawasaki disease is the … of acquired heart disease in kids in most developed countries, including the US and Japan

A

leading cause

48
Q

What is a good predictor of coronary artery involvement during follow-up of patients with kawasaki disease?

A

BSA-adjusted coronary artery dimensions on baseline TTE in the 1st 10 days of illness appears to be good predictors of involvement during follow-up

49
Q

What is the three phase pathological process described in arteriopathy in kawasaki disease?

A
  1. Neutrophilic necrotizing arteritis occuring in the 1st 2 weeks of illness. Begin in endothelium and move through the coronary wall. Saccular aneurysms may form from this arteritis
  2. Subacute/chronic vasculitis driven by lymphocytes, plasma cells, and eosinophils. May least weeks to years and results in fusiform aneurysms.
  3. The vessels affected by the subacute/chronic vasculitis then develop smooth muscle cell myofibroblasts, causing progressive stenosis in the 3rd phase
50
Q

what percentage of patients with kawasaki disease have confirmed, concurrent infections?

A

Up to 33%

51
Q

What symptoms other than the pricipical clinical criteria are common in the 10 days prior to kawasaki disease diagnosis?

A

Vomiting, diarrhoea, abdo pain –> >60%

At least 1 respiratory symptoms –> 35%

Irritability that is prominent in infants and likely caused by aseptic meningitis

Mild hepatitis

hydrops of the gallbladder

urethritis and meatitis with sterile pyuria

Arthritis

52
Q

What is Kawasaki disease shock syndrome? What are they at higher risk of?

A

KD presentations as cardiogenic shock

Diminished LV function

Higher risk of coronary artery dilation

53
Q

How often does mitral regurgitation occur in patients with kawasaki disease?

A

MR of at least mild severity is evident on TTE in 10-25% of pts at presentation but diminishes over time, except among rare pts with coronary aneuryms and IHD

54
Q

What is node-first kawasaki disease? Do they tend to be older or younger?

What do they have in addition to cervical adenopathy?

A

KD that initially presents with only fever and lymphadenopathy

Tend to be older (4 vs. 2yr)

Many have retropharyngeal and peritonsillar inflammation on CT scans, in addition to cervical adenopathy

55
Q

What are the 3 clinical phases of kawasaki disease?

A
  • Acute febrile phase: fever and other acute signs of illness, lasts 1-2 weeks
  • Subacute phase: desquamation, thrombocytosis, development of CAA, and highest risk of sudden death in pts who develop aneurysms, lasts 3 weeks
  • Convalescent phase: all clinical signs of illness have disappeared and continues until the ESR returns to normal, typically 6-8 weeks after the onset of illness
56
Q

Kawasaki disease is unlikely if….?

A

ESR, CRP, and platelets are normal after 7 days of fever

57
Q

What defines a small vs. medium vs. giant aneurysms in kawasaki disease?

A

Small = <4mm internal diameter

medium = Between 4-8mm internal diameter

giant = >8mm internal diameter

58
Q

What is the differential diagnosis of Kawasaki disease?

A